AstraZeneca bets on new cancer treatments with US$2 billion Fusion Pharma purchase
ASTRAZENECA said on Tuesday (Mar 19) it will buy clinical-stage biopharmaceutical company Fusion Pharmaceuticals for about US$2 billion in cash ...
ASTRAZENECA said on Tuesday (Mar 19) it will buy clinical-stage biopharmaceutical company Fusion Pharmaceuticals for about US$2 billion in cash ...
DRUGMAKER AstraZeneca said on Thursday (Mar 14) it would acquire rare endocrine diseases-focused firm Amolyt Pharma for US$1.05 billion in ...
ASTRAZENECA expects to boost revenue and profit this year on the back of resilient demand for its cancer and rare ...
KEY POINTSAstraZeneca said it will exit the manufacturing site in the city of Bengaluru in due courseIt will search for ...
AstraZeneca has developed a new pill that significantly reduces the chances of death from lung cancer. The drug named osimertinib ...
A British coroner has judged that the death of a London doctor in 2021 was directly related to the Covid-19 ...
People pose with syringe with needle in front of displayed AstraZeneca logo in this illustration taken, December 11, 2021. Reuters ...
Pascal Soriot, chief executive of pharmaceuticals company AstraZeneca, attends an interview with Reuters in Shanghai, China, November 4, 2019. AstraZeneca ...
International Business Weekly is an American entertainment magazine. We cover business News & feature exclusive interviews with many notable figures
Copyright © 2024 - International Business Weekly